🎉 That’s a wrap on the ADVANCE-ID Clinical Trial Workshop 2026! 2.5 days of learning, discussions, collaboration & research pitches. A big thank you to our speakers, facilitators, panellists & participants for making it a success! 🌏🔬 #ClinicalTrials #ClinicalResearch #GlobalHealth #Collaboration

Demystify clinical trial design & enhance your research toolkit!📊✨ Join our statistical seminars supported by ADVANCE-ID & WHO. Explore clinical trial theory & real-life examples with global experts. Master the numbers in the mission against disease here: ad-id.co/stats #WHO #statistics #clinical

📢 Join us online for ADVANCE-ID's Clinical Trial Workshop 2026 (31 Aug – 2 Sep), featuring a special WHO Collaborating Centre launch. Register to join virtually via Zoom 💻 🔗 forms.cloud.microsoft/r/XitvsiRUxL #ADVANCE_ID #CTW2026 #WHOCC

Demystify clinical trial design & enhance your research toolkit! 📊✨ Join our statistical seminars: ad-id.co/stats #statistics #stats #clinicaltrials #data #seminar

Demystify clinical trial design & enhance your research toolkit!📊✨ Join our statistical seminars supported by @advance-id.bsky.social & @who.int Explore clinical trial theory & real-life examples with global experts. Master the numbers in the mission against disease here: ad-id.co/stats

🚀 Due to continued interest in our Rapid Diagnostics Open Call, we’re extending the deadline to 30 August 2026! 🗒️ Submit your Expression of Interest now! forms.office.com/r/rt77z5X4fD Find out more: ad-id.co/dt

TREAT-GNB has reached 100 participants! THANK YOU to all site investigators & regional leads for making this milestone possible. As the 1st platform trial for severe Gram-negative bacilli infections, we've enrolled participants across Singapore, China, Thailand, Spain & Australia #TREATGNB #AMR

📢 Our Rapid Diagnostics Open Call for AMR closes on 16 August 2026 If you have a rapid diagnostic product—or one in development—that fits our Open Call, share with us by submitting your interest before the deadline: lnkd.in/gr9qWbDD 🔗 Open Call details, TPP and EOI reference form: ad-id.co/dt

It was a productive week for the ADVANCE-ID team in Malaysia as we continue preparations for the TREAT-GNB platform trial. Our visit included engagements with the Institute for Clinical Research (ICR), Malaysia, as well as Universiti Sains Malaysia (USM) and #APSIC2026 Conference.

⏰ Reminder: Our Rapid Diagnostics Open Call for AMR is now accepting submissions. Submit your Expression of Interest (EOI) by 16 August 2026. 📋 lnkd.in/gr9qWbDD Target Product Profile and an EOI reference form are available on our website ad-id.co/dt.

We are delighted to share that our latest research has been published in The Lancet Regional Health – Western Pacific! New antibiotics can only save lives if patients who need them are able to access them. 📄Read the paper here: www.sciencedirect.com/science/arti...

Developing innovative rapid diagnostic solutions for Antimicrobial Resistance (AMR)? 🚀 Our Rapid Diagnostics Open Call for AMR is now open! Submit your Expression of Interest at 📋 forms.office.com/r/rt77z5X4fD before 16 August 2026! 🗓️ Find out more at ad-id.co/dt

🚀 Help shape a global community for early-career researchers in antimicrobial R&D. If you're a student, PhD candidate, postdoc, clinician or early-career professional, take 8–10 min #REVIVE survey today. Senior researchers are welcome too! 🔗 https://office.pulse.ly/1nwkdbgjhe

✨ Invitation to join our ADVANCE-ID Seminar Series! Join us for an upcoming online seminar on 10 Jul 2026 (5-6.15pm SGT), featuring European Society of Clinical Microbiology and Infectious Diseases (ESCMID) highlights and a sharing on our Data Governance Guidelines. 🔗 Register here: ad-id.co/s2

💻 Missed our webinar? You can now watch (or rewatch) it on our website. 🚨 1 week to go until our Rapid Diagnostics Open Call for AMR! Open Call details and Target Product Profile are now available on the DETECT website: ad-id.co/dt ❓ Have questions? Reach out to the DETECT team via: ad-id.co/dtq

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)@advance-id.bsky.social · 3mo ago

Our webinar is just one week away Developing a rapid diagnostic for AMR? Join us to: ✅ Understand what technologies we're looking for ✅ What makes a rapid diagnostic clinically useful ✅ Learn about regulatory pathways in Asia and early development considerations ‼️ Register now: lnkd.in/gKNh-wda

📢 Leadership Update at ADVANCE-ID 🌟 A/Prof Mo Yin, ID physician & clinician-scientist, has been appointed Director of ADVANCE-ID, effective 1 Jul 2026. Prof David Paterson, inaugural Director, transitions to Executive Chair. Read more: ad-id.co/ldrt

✨ Invitation to join our ADVANCE-ID Seminar Series! Join us for an upcoming online seminar on 10 Jul 2026 (5-6.15pm SGT), featuring European Society of Clinical Microbiology and Infectious Diseases (ESCMID) highlights and a sharing on our Data Governance Guidelines. 🔗 Register here: ad-id.co/s2

Our webinar is just one week away Developing a rapid diagnostic for AMR? Join us to: ✅ Understand what technologies we're looking for ✅ What makes a rapid diagnostic clinically useful ✅ Learn about regulatory pathways in Asia and early development considerations ‼️ Register now: lnkd.in/gKNh-wda

ADVANcing Clinical Evidence in Infectious Diseases (ADVANCE-ID)@advance-id.bsky.social · 3mo ago

Developing an affordable AMR rapid diagnostic? Join our webinar on 23 Jun 2026, 6–7 PM SGT. Learn what makes a diagnostic clinically useful, common development gaps, regulatory considerations in Asia, and details of our upcoming open call. Register: ad-id.co/3Slr0xF #AMR @carb-x.bsky.social

📢 Applications Now Open: CDA Short-Term Fellowship FY2026 (Round 2) Are you looking to build or strengthen international collaborations in infectious disease research? Application deadline: 19 June 2026 Email us to find out more: hello@advance-id.network #callforapplications #shorttermfellowship

🌍🎥 #ACC2026 session recordings are now available with subtitles in English, Japanese and Thai. From discovery to clinical development, revisit expert-led discussions across antimicrobial R&D — now more accessible globally. 🔗 Watch: acc-conference.com

Developing an affordable AMR rapid diagnostic? Join our webinar on 23 Jun 2026, 6–7 PM SGT. Learn what makes a diagnostic clinically useful, common development gaps, regulatory considerations in Asia, and details of our upcoming open call. Register: ad-id.co/3Slr0xF #AMR @carb-x.bsky.social

👇 Now available online in #CID ADVANCE-ID: Conducting Innovative Clinical Trials and Promoting Access for Antibiotics in Asia (Vol. 82, Supplement 5; 15 June 2026) A timely collection of papers on antibiotic evidence generation and access in Asia. 🔗Link: ad-id.co/cid #AMR #CIDJournal #Antibiotics

🌟 One month to apply 🌟 Travel Awards for ICC 2026, Manila Open to Young Investigators (<35) from ISAC Member Societies, including Eastern Europe. Awardees receive €1,000 towards travel + accommodation. Apply now: www.isac.world/awards/young... @heiman-wertheim.bsky.social @souhakanj.bsky.social

Happy Clinical Trials Day from ADVANCE-ID! We are grateful to contribute to ongoing work in ID research through studies such as TREAT-GNB, RAPID and Phase II (RIV-CARE), advancing innovation against AMR through collaboration and clinical research. #ClinicalTrialsDay #CTD2026

We are excited to be part of the Philanthropy Asia Summit 2026 (18-20 May'26, Sands Expo and Convention Centre, Marina Bay Sands, #Singapore)! Come visit us at our booth to learn more about our work in ID research, clinical trials, and global collaborations! #PAS2026

Applications Open: 2026 Singapore–Southeast Asia Fellowship (S-SEAF) Supports research collaboration, talent mobility & knowledge exchange (ID focus) Options: 2-year or ≥ 6 months Apply by 1 Aug 2026 🔗https://ad-id.co/42NPdib 📅 Webinar: 19 May 2026 🔗 ad-id.co/3R4mjI0

How do you diagnose and treat Chronic Bacterial Prostatitis (CBP)? Help improve research and clinical care for CBP, a challenging infection in outpatient clinics by helping to complete the practice survey on CBP. ⏱ Takes 5–7 minutes: lnkd.in/ejQFEeDP

📢 Shared opportunity: IE Registry road-testing now open Participating centres are invited to suggest: 1 complex and 1 simple patient per centre using standard registry fields including time taken and suggestions. Deadline: 29 April 2026 Registry field PDFs: www.endocarditis.au

We’re delighted to share that IHRI held its second CAG meeting, reaching a consensus to expand beyond recruitment to engagement across the clinical trial lifecycle - tackling mistrust, power gaps, and legal barriers, and seeking to uncover the truth behind public disengagement.

Our team will be actively presenting at #ESCMID2026 showcasing key work in antimicrobial resistance (AMR), Gram-negative infections, and innovative clinical trial approaches. 📍 Join us from 17–21 April 2026 to connect, learn, and engage with us: ad-id.co/escmid26